SIGA logo

SIGA Technologies Inc. (SIGA)

$2.85

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on SIGA

Market cap

$204786793

EPS

0.01

P/E ratio

--

Price to sales

4.39

Dividend yield

--

Beta

1.103663

Price on SIGA

Previous close

$2.74

Today's open

$2.74

Day's range

$2.66 - $2.94

52 week range

$2.66 - $7.11

Profile about SIGA

CEO

Diem Nguyen

Employees

49

Headquarters

New York, NY

Exchange

NASDAQ Global Market

Shares outstanding

71855015

Issue type

Common Stock

SIGA industries and sectors

Healthcare

Pharmaceuticals

News on SIGA

SIGA Technologies, Inc. (SIGA) Q3 2026 Earnings Call Transcript

SIGA Technologies, Inc. (SIGA) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 10, 2026

news preview

What Siga Technologies (SIGA) Said on Its Q3 Earnings Call

Siga Technologies NASDAQ: SIGA said it continues to expect a new U.S. government procurement contract for its smallpox treatment TPOXX, although the timing remains uncertain after a slower-than-expected contracting process.

news source

MarketBeat • Nov 10, 2026

news preview

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2026

Awarded $15 Million Procurement Contract from Canadian Department of National Defence for Oral TPOXX in October  Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and nine months ended September 30, 2026. “While we continue to work with the U.S. Government toward a new TPOXX procurement contract, our international business remains an important part of our strategy,” stated Diem Nguyen, Chief Executive Officer.

news source

GlobeNewsWire • Nov 9, 2026

news preview

SIGA Announces Retirement of Chief Scientific Officer Dennis Hruby, Ph.D.

NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies (NASDAQ: SIGA), a commercial stage pharmaceutical company, announced today that Dennis Hruby, Ph.D., Executive Vice President and Chief Scientific Officer, will retire effective today, concluding more than 30 years with the Company.

news source

GlobeNewsWire • Nov 9, 2026

news preview

SIGA to Host Business Update Call on November 9, 2026, Following Release of Third-Quarter 2026 Financial Results

NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Monday, November 9, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer.

news source

GlobeNewsWire • Oct 29, 2026

news preview

SIGA Secures Contract Valued at Up to $15 Million from Canadian Department of National Defence to Purchase TPOXX®

Continues Canada's commitment to smallpox preparedness for the Canadian Armed Forces Continues Canada's commitment to smallpox preparedness for the Canadian Armed Forces

news source

GlobeNewsWire • Oct 28, 2026

news preview

Siga Technologies Q2 Earnings Call Highlights

Siga Technologies NASDAQ: SIGA reported second-quarter product-related revenue of $38 million, driven primarily by deliveries of intravenous TPOXX to the U.S. Strategic National Stockpile and oral TPOXX sales to international customers. The company said the quarter reflected the variable timing of its government-focused procurement business after minimal product revenue in the first quarter.

news source

MarketBeat • Aug 7, 2026

news preview

SIGA Technologies, Inc. (SIGA) Q2 2026 Earnings Call Transcript

SIGA Technologies, Inc. (SIGA) Q2 2026 Earnings Call Transcript

news source

Seeking Alpha • Aug 7, 2026

news preview

SIGA to Host Business Update Call on August 6, 2026, Following Release of Second-Quarter 2026 Financial Results

NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, August 6, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer.

news source

GlobeNewsWire • Jul 30, 2026

news preview

Siga Technologies: Q2 Earnings Due, New TPOXX Orders A Must

Siga Technologies, Inc. remains a Hold, as revenue visibility hinges on BARDA contract renewal, with shares down ~40% since April. SIGA's sole commercial product, TPOXX, faces shrinking opportunities after losing EU approval for MPOX although mgmt is developing pediatric and PEP versions. Q1 2026 results showed stagnant revenues, widening losses, and reliance on a $26m BARDA delivery and $13m Asia Pacific contract.

news source

Seeking Alpha • Jul 28, 2026

news preview

¹ Disclosures

Get started with M1

Invest in SIGA Technologies Inc.

Open an M1 investment account to buy and sell SIGA Technologies Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in SIGA on M1